Clinical Pharmacist Beneficiation in Countries with Highest Covid-19 Cases – A Short Communication
Abstract
On 31st December 2019, a new-born highly contagious virus had evolved as a public health crisis from the point of the outbreak. Perceiving risk of acquiring the disease almost all nations were in lockdown to break the chain of SARS-CoV-2 chain first identified in Wuhan, the mainland of China.1, 2 As history was rewritten due to stringent lockdown around
the globe to avoid the spread of COVID-19 infection. Health care workers which include pharmacist had acted as frontline workers who had served as a saviour to fight the battle against COVID-19.
How to cite this article: Chaturvedi B, Singh P, Suman S et al. Clinical Pharmacist Beneficiation in Countries with Highest Covid-19 Cases – A Short Communication.
Rec Trends Pharm Tech Ind 2020; 2(1): 9-11.
References
Bukhari N, Rasheed H, Nayyer B et al. Pharmacists at the frontline beating the COVID-19 pandemic. Journal of Pharmaceutical Policy and Practice 2020; 13(1).
Hedima EW, Adeyemi MS, Ikunaiye NY. Community Pharmacists: on the frontline of health service against COVID-19 in LMICs. Res Soc Adm Pharm 2020.
Bhat S, Farraye FA, Moss A. Roles of clinical pharmacists in caring for patients with inflammatory bowel disease during COVID-19. Gastroenterology 2020.
Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle- income countries. Res Soc Adm Pharm 2020.
Song Z, Hu Y, Zheng S et al. Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: recommendations and guidance from clinical experience. Res Soc Adm Pharm 2020.
International Pharmaceutical Federation. COVID-19: guidelines for pharmacists and the pharmacy workforce. Available from: https://www.fip.org/files/content/prior ity-areas/coronavirus/COVID-19-Guidelines-for-pharmacists-and-the-pharma cy-workforce.pdf.
Accessed date: 08.07.20.
Khan Z, Muhammad K, Ahmed A et al. Coronavirus outbreaks: prevention and management recommend- ations. Drugs Ther Perspect. 2020; 36: 215–217.
Lia H, Zhenga S, Liua F et al. Fighting against COVID-19: innovative strategies for clinical pharmacists. Res Soc Adm Pharm 2020.
Peters MDJ, Godfrey C, McInerney P et al. Chapter 11: scoping reviews (2020 version). Available from. In: Aromataris E, Munn Z, eds. Joanna Briggs Institute Reviewer’s Manual JBI 2020.
American Pharmacists Association [Internet]. Pharmacist.com. 2020 [cited 8 July 2020]. Available from: http://www.pharmacist.com
Li H, Zheng S, Liu F et al. Fighting against COVID-19: Innovative strategies for clinical pharmacists. 2020.
Poh A, Lin W. Role of the pharmacist during the COVID-19 pandemic: a time to rethink strategies. Singapore Medical Journal 2020.
Dourado I, Magno L, Soares F et al. Adapting to the COVID-19 Pandemic: Continuing HIV Prevention Services for Adolescents Through Telemonitoring, Brazil. AIDS and Behavior 2020; 24(7): 1994-1999.
M G, LN S. COVID-19: A ‘Violent’ pandemic for health care workers in India. COVID-19 Special Issue. 2020; 1(2): 32-40.
